We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2809:TSEKewpie Corporation Analysis

Data as of 2026-03-14 - not real-time

¥4,292.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kewpie Corp trades around ¥4,292, sitting just above the identified support of ¥4,252 and well below the 20‑day SMA of ¥4,456.9, indicating a short‑term price cushion but a longer‑term bullish bias as the 20‑day SMA remains above the 50‑day (¥4,412) and 200‑day (¥4,111) averages. Technical momentum shows a bearish MACD histogram and a signal line in the negative zone, yet the RSI of 39.8 suggests the stock is approaching oversold conditions, potentially priming a rebound. Fundamentally, the company posts a healthy dividend yield of 1.54% with a modest payout ratio of 24%, strong cash reserves (¥80.6 bn) versus debt (¥20.8 bn), and a forward PE of 23.99, aligning with its defensive consumer sector profile. Analysts are optimistic, averaging a target price of ¥4,900, implying roughly 11% upside despite a DCF‑derived fair value of ¥2,286 that flags a valuation gap.
The overall risk picture is moderate: a low beta of –0.06 and a defensive industry mitigate systematic risk, while a 30‑day volatility of 23% introduces price swing potential. The dividend appears sustainable, and the company’s modest revenue growth of 5.6% together with a solid ROE near 10% supports a buy stance for medium‑ to long‑term horizons, while short‑term positioning may warrant a cautious hold until technical confirmation emerges.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support
  • RSI approaching oversold levels
  • Bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus buy with median target ¥4,900
  • Sustainable dividend and low payout ratio
  • Defensive consumer sector with stable cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong brand and diversified product portfolio
  • Low beta and defensive industry reducing systematic risk
  • Consistent earnings and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin5.94%
P/E Ratio19.5
ROE9.98%
ROA4.57%
Debt/Equity5.98
P/B Ratio1.8
Op. Cash Flow¥31.8B
Free Cash Flow¥14.8B

Technical Analysis

TrendBullish
RSI39.8
Support¥4,252.00
Resistance¥4,646.00
MA 20¥4,456.90
MA 50¥4,412.24
MA 200¥4,111.23
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value¥2,285.67
Target Price¥4,768.75
Upside/Downside11.11%
GradeFair
TypeBlend
Dividend Yield1.54%

Risk Assessment

Beta-0.11
Volatility23.14%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.